An epidemic that continues to grow.
Faced with this global health emergency, as declared by the Director General of the World Health Organization (WHO) at the end of July, an effective weapon: vaccination.
And good news, the European Medicines Agency (EMA) has just authorized a new vaccine inoculation technique.
A new mode of injection which should make it possible to immunize more people.
Read alsoWhy is monkeypox still called monkeypox?
European countries can now administer the Imvanex vaccine just under the upper layer of the skin (intradermally) and no longer deep (subcutaneously) as is currently the case, and thus only use a fifth of the dose, the EMA said in a statement.
Better access to vaccination
This technique which uses a lower dose of vaccine produces the same immunity with an equivalent level of antibodies as the other method, but the risk of skin irritation is higher, the Amsterdam-based watchdog has warned .
European Commissioner Stella Kyriakides stressed that this authorization was an “extremely important decision because it makes it possible to vaccinate five times more people with the stocks of vaccines that we currently have”.
“This ensures better access to vaccination for people at risk and healthcare professionals,” she added in a statement.